Panakeia
PrivateLast Round
Grant
Jul 1, 2024
Est. Valuation
$10.7M
Total Funding Raised
$9.49M
Company Overview
Panakeia operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in July 2024.
Panakeia is a biotechnology company that provides an AI-driven software platform for multi-omic biomarker profiling directly from tissue images to accelerate cancer diagnosis and inform precision treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Drug Discovery, Precision Medicine, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panakeia Comparables
Compare Panakeia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleai | 85% | |
| Imagene AI | 84% | |
| Aignostics | 81% |
For institutional investors. Book with your work email.
Panakeia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2024 | ||||
| Grant | Apr 1, 2023 | ||||
| M&A | Sep 9, 2021 | ||||
| Seed | Oct 27, 2020 | ||||
| Grant | May 20, 2020 | ||||
Seed | Sep 26, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Panakeia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Hoxton Ventures | Seed |
| Innovate UK | Grant |
| Phoenix Court Group | Seed |
| LocalGlobe | Seed |
| Entrepreneurs First | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Landmark metabolic and pathway activation data presented at AACR 2026.
- Apr 21, 2026
Presented new data at the AACR 2026 conference.
For institutional investors. Book with your work email.
Panakeia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Panakeia's valuation, stock price, and market status.
Is Panakeia a public or private company?
Panakeia is a private company.
What is the current stock price of Panakeia?
Panakeia is a private company, so its shares have no public market price. Caplight tracks Panakeia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Panakeia worth (valuation)?
Panakeia's valuation is estimated at $10.7M based on funding round data.
Can I buy Panakeia stock?
Panakeia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Panakeia's last funding round?
Panakeia's most recent funding round was Grant on July 1, 2024.
Who are the main investors in Panakeia?
Key investors in Panakeia include Innovate UK, Hoxton Ventures, Phoenix Court Group, Entrepreneurs First.
Will Panakeia IPO soon?
No public IPO plans have been announced for Panakeia.
How can I track Panakeia secondary market activity?
Caplight tracks bids, offers, and trades in Panakeia's shares on secondary markets.